Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pancreatic Diseases: full-pipeline trial registry
3 of 6 indexed Pancreatic Diseases trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Pancreatic Diseases: 6 US clinical trials tracked, 3 recruiting.
Pancreatic Diseases is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Do Hyun Park, running 1 of these trials.
Enrollment posture brief
Registry condition pancreatic-diseases
OPEN 3 | RECR 50% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Pancreatic Diseases lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pancreatic Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pancreatic Diseases is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pancreatic Diseases research.
Do Hyun Park accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Pancreatic Diseases enrolment sits around 700 participants.
Median target enrolment is 700 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Pancreatic Diseases splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
UCSF PANC Cyst Registry
University of California, San Francisco
NCT04291651
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Memorial Sloan Kettering Cancer Center
NCT03334708
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
Do Hyun Park
NCT07030348
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
Mayo Clinic
NCT04329039
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Celgene
NCT01964430
Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
Children's Hospital of Philadelphia
NCT03303196
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pancreatic Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pancreatic Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pancreatic Diseases page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Pancreatic Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Do Hyun Park sponsors the most Pancreatic Diseases trials on record, review their full trial history before evaluating a specific study. See Do Hyun Park's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pancreatic Diseases condition card totals 6 registered trials; most-linked intervention Bihormonal Bionic Pancreas; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.